行情

CUR

CUR

Neuralstem
NASDAQ

实时行情|Nasdaq Last Sale

1.680
-0.150
-8.20%
已收盘, 16:00 09/18 EDT
开盘
1.840
昨收
1.830
最高
1.841
最低
1.600
成交量
9.20万
成交额
--
52周最高
24.40
52周最低
1.500
市值
352.85万
市盈率(TTM)
-0.0109
分时
5日
1月
3月
1年
5年

EPS

CUR 新闻

  • 连续三天!美联储计划再进行750亿美元隔夜回购操作
  • 新浪财经综合.2小时前
  • 微软宣布400亿美元股票回购 盘后股价上涨1.3%
  • 新浪美股.3小时前
  • 新iPhone预售“真香” 苹果公司却一年痛失三位高管
  • 新浪美股.3小时前
  • 罢工导致工厂放缓 通用汽车在加拿大临时裁员1200人
  • 新浪美股.3小时前

更多

所属板块

制药
0.00%
制药与医学研究
-0.14%

热门股票

名称
价格
涨跌幅

CUR 简况

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform. The Company's technology allows the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the treatment of central nervous system diseases and conditions. The Company is developing NSI-189 for the treatment of major depressive disorder (MDD) and other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy. The Company's NSI-566 is indicated for amyotrophic lateral sclerosis (ALS), chronic spinal cord injury and motor deficits due to ischemic stroke.
展开

Webull提供Neuralstem, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。